Ardelyx (ARDX) Peer Comparison

$3.84

$0.02 (0.52%)

As on 28-Aug-2026 13:40EDT

Market cap

$1,004 Mln

Revenue (TTM)

$451 Mln

P/E Ratio

--

P/B Ratio

6.8

Div. Yield

0 %

Edit

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	1,004	17,326	16,614	13,400	12,305
Revenue ($ Mln)	451	2,782	1,054	2,436	670
Net Profit ($ Mln)	-55.70	491.50	755.85	860.62	-319.95
Net Margin (%)	-12.35	17.67	71.69	35.33	-47.79
RoE (%)	-35.26	110.09	--	42.98	-71.14
Price to Earnings	--	36.49	19.38	17.01	--
Price-To-Book	6.76	39.43	10.05	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	450.89	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	27.23	1,982.07	103.47	85.67	19.14
Gross Profit	364.72	760.62	588.53	2,236.43	829.45
Operating Expenses	459.12	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-35.45	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-55.48	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.23	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-55.70	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	149.01	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	294.66	187.89	384.48	288.55	1,362.63
Current Liabilities	132.22	1,435.43	464.70	361.93	283.35
Total Liabilities	501.60	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	133.97	1,006.90	895.24	1,243.41	440.60
Current Assets	441.93	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	501.60	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	256.19	120.10	449.89	165.93	864.07
Net Current Assets	309.71	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-42.48	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-8.96	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	54.51	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-17.47	53.56	-30.01	32.82	-0.17
ROE (%)	-35.26	110.09	163.18	42.98	-71.14
ROA (%)	-8.87	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-6.22	21.13	5.73	31.04	-0.77
Net Margin (%)	-12.35	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	16.77	24.67	114.85	9.23	12.22
EBIT Growth (%)	10.92	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	1.21	17.50	378.76	42.89	-115.58
EPS Growth (%)	4.36	26.84	353.27	50.42	-73.87
Book Value Growth (%)	3.29	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-23.06	36.06	-59.76	15.79	-2,869.63
Price / Book Value	8.51	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-46.86	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	1.69	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.01	0.00	0.05	0.00	0.09
Current Ratio	3.34	0.73	2.99	3.46	5.90
Quick Ratio	3.15	0.73	2.32	3.38	5.90
Interest Coverage	-1.02	--	1.62	--	-1.72

Operating Efficiency Ratios

	Ardelyx (ARDX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	22.26	15.88	21.25	13.74	1.28
Asset Turnover	0.72	0.89	0.37	0.83	0.34
Receivable days	58.09	50.42	85.52	43.48	1.50
Inventory Days	166.81	--	1,056.70	96.17	--
Payable days	151.07	6.26	331.01	147.97	221.81
Cash Conversion Cycle	73.83	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly